[Therapeutic approaches in children immunized with vaccine Prevenar].
Cohen
R
R
Aujard
Y
Y
Bingen
E
E
Boucherat
M
M
Bourrillon
A
A
Foucaud
P
P
Francois
M
M
Garnier
J M
JM
Guillot
M
M
Ovetchkine
P
P
Ployet
M J
MJ
Quinet
B
B
Gaudelus
J
J
D000208:Acute Disease; D000367:Age Factors; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D016470:Bacteremia / Q000517:prevention & control*; D002648:Child; D002675:Child, Preschool; D004352:Drug Resistance, Microbial; D000069443:Heptavalent Pneumococcal Conjugate Vaccine; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008585:Meningitis, Meningococcal / Q000517:prevention & control*; D008586:Meningitis, Pneumococcal / Q000517:prevention & control*; D022401:Meningococcal Vaccines / Q000008:administration & dosage*; D010033:Otitis Media / Q000517:prevention & control*; D022242:Pneumococcal Vaccines / Q000008:administration & dosage*; D011014:Pneumonia / Q000517:prevention & control*; D012008:Recurrence; D013296:Streptococcus pneumoniae / Q000187:drug effects; D018074:Vaccines, Conjugate / Q000008:administration & dosage*
D000900:Anti-Bacterial Agents; D000069443:Heptavalent Pneumococcal Conjugate Vaccine; D022401:Meningococcal Vaccines; D022242:Pneumococcal Vaccines; D018074:Vaccines, Conjugate